Showing results (1411-1420 of 1,430) with videos related to
Sort By:
Pageof 143
Journal of Medicinal Chemistry|March 13, 2015
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer AgentsYong Liu, Yunhui Lang, Narendra Kumar Patel, et al.Proceedings of the National Academy of Sciences of the United States of America|February 9, 2019
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancerShawn P Kubli, Christian Bassi, Cecilia Roux, et al.Cell Metabolism|March 28, 2020
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell FunctionHenry Kurniawan, Davide G Franchina, Luana Guerra, et al.Biorxiv : the Preprint Server for Biology|March 27, 2026
MAIT cell responses to <i>S. aureus</i> and sensitivity to HlgAB are modulated by activation and tissue-dependent virulence effectsElisa J M Raineri, Caroline Boulouis, Elli Mouchtaridi, et al.Science Immunology|September 6, 2024
MAIT cell heterogeneity across paired human tissues reveals specialization of distinct regulatory and enhanced effector profilesTobias Kammann, Curtis Cai, Takuya Sekine, et al.Genes & Development|May 18, 2011
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressKathrin Zaugg, Yi Yao, Patrick T Reilly, et al.Cell Stem Cell|October 23, 2018
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic ScreeningHelen H N Yan, Hoi Cheong Siu, Simon Law, et al.Cancer Discovery|July 24, 2021
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML TherapyHsin-Chieh Wu, Domitille Rérolle, Caroline Berthier, et al.Cancer Cell|April 5, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendrogliomaAvishay Spitzer, Simon Gritsch, Masashi Nomura, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i><sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.Pageof 143